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Abstract 
Aims: The purpose of this multi-phase explorative in vivo animal/surgical and 
in vitro multi-test experimental study was to (1) create a 3 wt%-
nanostrontium hydroxyapatite-enhanced calcium phosphate cement (Sr-
HA/CPC) for increasing bone formation and (2) creating a simvastatin-loaded 
poly(lactic-co-glycolic acid) (SIM-loaded PLGA) microspheres plus CPC 
composite (SIM-loaded PLGA + nanostrontium-CPC). The third goal was the 
extensive assessment of multiple in vitro and in vivo characteristics of the 
above experimental explorative products in vitro and in vivo (animal and 
surgical studies). 
Methods and results pertaining to Sr-HA/CPC: Physical and chemical 
properties of the prepared Sr-HA/CPC were evaluated. MTT assay and alkaline 
phosphatase activities, and radiological and histological examinations of Sr-
HA/CPC, CPC and negative control were compared. X-ray diffraction (XRD) 
indicated that crystallinity of the prepared cement increased by increasing the 
powder-to-liquid ratio. Incorporation of Sr-HA into CPC increased MTT assay 
(biocompatibility) and ALP activity (P < 0.05). Histomorphometry showed 
greater bone formation after 4 weeks, after implantation of Sr-HA/CPC in 10 
rats compared to implantations of CPC or empty defects in the same rats 
(n = 30, ANOVA P < 0.05). 
Methods and results pertaining to SIM-loaded PLGA 
microspheres + nanostrontium-CPC composite: After SEM assessment, 
the produced composite of microspheres and enhanced CPC were implanted 
for 8 weeks in 10 rabbits, along with positive and negative controls, enhanced 
CPC, and enhanced CPC plus SIM (n = 50). In the control group, only a small 
amount of bone had been regenerated (localized at the boundary of the 
defect); whereas, other groups showed new bone formation within and 
around the materials. A significant difference was found in the osteogenesis 
induced by the groups sham control (16.96 ± 1.01), bone materials 
(32.28 ± 4.03), nanostrontium-CPC (24.84 ± 2.6), nanostrontium-CPC-
simvastatin (40.12 ± 3.29), and SIM-loaded PLGA + nanostrontium-CPC 
(44.8 ± 6.45) (ANOVA P < 0.001). All the pairwise comparisons were 
significant (Tukey P < 0.01), except that of nanostrontium-CPC-simvastatin 
and SIM-loaded PLGA + nanostrontium-CPC. This confirmed the efficacy of 
the SIM-loaded PLGA + nanostrontium-CPC composite, and its superiority 
over all materials except SIM-containing nanostrontium-CPC. 
 
Keywords: Biomaterials, Drug delivery systems, Calcium phosphate cement 
(CPC), Strontium, Hydroxyapatite, Brushite, Bone formation, Simvastatin, 
Poly(lactic-co-glycolic acid) microspheres 
1. Introduction 
In 1980s, calcium phosphate cements (CPCs) were discovered 
by LeGeros and Chow et al.1 Calcium phosphate cements are used as 
the bone substitute materials and can serve as injectable pastes to fill 
defects, while being biocompatible and osteoconductive.2,3 A bioactive 
material is one that can bind with the surrounding bone without the 
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formation of fibrous tissue.4 Bioactivity, together with the perfect 
adaptability of the cement paste leads to a stable connection between 
defect and implant and boost bone healing process.5,6 The main 
reaction of calcium phosphate cements is the cementing action of 
acidic and basic calcium phosphate compounds in an aqueous 
solution.1,2,7 Calcium phosphate cements are formed by a chemical 
reaction between two phases: the dry powder phase which is a 
combination of calcium orthophosphate, and the liquid phase which is 
water or a calcium or phosphate-containing aqueous solution.1,2,4,7,8 
After mixing the powder phase with the liquid phase, a paste forms 
that sets and hardens into a solid mass. One of the advantages of 
calcium phosphate cements is that no heat is generated during 
cementation reaction and the cementation process is not exothermic 
(thus, no risk of hyperthermia).2,3,7,9,10 Furthermore calcium phosphate 
cements are intrinsically microporous, as a result of extra aqueous 
solution leaving the material after hardening. This property can be 
used for carrying of biological fluids into CPCs and causes degradation 
and replacement of CPCs by bone. Degradation rate depends on the 
composition and microstructure of the cement. Degradation products 
are well absorbed by the surrounding tissues.11,12,13,14 
Despite having many advantages, calcium phosphate cements 
have some drawbacks including poor mechanical properties. Like most 
ceramics, they are brittle. Furthermore, due to their intrinsic porous 
structure, their strength is lower than acrylic cements. This drawback 
has limited their application.11,15,16,17 
There are two main calcium phosphate cements: hydroxyapatite 
and dicalcium phosphate dehydrate (brushite). The final product 
formed by the liquid and solid phase depends on pH of the solution. 
Hydroxyapatite forms in pHs higher than 4.2 while brushite (DCPD) 
forms when the pH is lower than 4.2. Solubility of brushite is greater 
than hydroxyapatite at physiological pH. In fact brushite is metastable 
under physiological conditions and can be resorbed more quickly than 
hydroxyapatite.2,8,18 
Brushite cements have generally short setting times (about 30 
to 60 s) that limit their use as orthopedic applications. To make these 
cements suitable for orthopedic usage, specific setting retardants 
(such as pyrophosphate ions or citrates) are usually added to slow 
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down the setting process by inhibiting nucleation and growth of 
calcium phosphate crystals.7,16,19,20 Moreover, some ions like Sr, Zn, 
and Mg can serve as enzyme cofactors in bone regeneration 
process.21,22,23 Thus, the incorporation of these ions in biomaterials can 
improve bone tissue healing.24,25 
Strontium can stimulate osteoblast differentiation and inhibit 
osteoclast activity and therefore is a valuable ion in treatment of 
osteoporosis. Hence, there are interests in incorporating strontium in 
calcium phosphate cements. Incorporation of strontium affects the 
reactivity of the cement but can also modify the final composition of 
the material.24,25,26 
A recent advent in pharmacology is solid polymer biodegradable 
particulates such as micro and sub-micron spheres with high 
dissolution rates, which might be of use in locally targeted 
pharmaceutical delivery and regeneration of injured tissues.27,28,29 
Because of their biodegradation potential and physiological removal, 
poly(lactic-co-glycolic acid) (PLGA) microspheres might be a proper 
candidate for such drug delivery systems.28,30,31 Simvastatin (SIM) is a 
hypolipidemic drug capable of inducing bone regeneration; hence it 
might be loaded into PLGA microspheres to possibly improve stability 
of microspheres after formation while also improving the bone 
regeneration.28,32,33 
In this study, the structural, physicochemical and biological 
properties of the type of calcium phosphate cements modified by 
strontium ion were evaluated. Also its effect on bone generation was 
examined. Afterwards, a new form of SIM-PLGA was created by the 
addition of nanostrontium-enhanced CPC. Its efficacy in improving 
osteogenesis was assessed. 
2. Materials and methods 
2.1. Overview 
In the first phase of this study (in vitro), an optimum ratio of 
power to liquid (P/L) was selected (among three available ratios) for 
producing 3 wt% nanostrontium-enhanced CPC with the best in vitro 
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properties. The recommended ratio was then used in next phases: in 
the second phase, the 3 wt% nanostrontium-enhanced CPC was 
assessed with various in vitro biological tests and then was compared 
against CPC as well as negative controls in rat. In the third phase (in 
vitro), the nanostrontium-enhanced CPC was composited with 
simvastatin-loaded poly(lactic-co-glycolic acid) (SIM-loaded PLGA) 
microspheres. In the last phase the properties of this “SIM-loaded 
PLGA + 3 wt% nanostrontium-enhanced CPC” composite biomaterial 
was evaluated in vitro. Then efficacy of this composite material in 
ontogenesis induction was evaluated in vivo (rabbit) against the 
materials: 3 wt% nanostrontium-enhanced CPC and 3 wt% 
nanostrontium-enhanced CPC plus simvastatin, a negative control 
(sockets left empty after bone trephining) as well as a positive control 
(experimental bone defects filled with the animal's trephined bone 
transplanted from the negative control sites). This study was 
conducted in accordance with the regulations and approval of the 
Institutional Animal Care and Ethical Committee of the Tehran 
University of Medical Sciences. 
2.2. Preparation of nanostrontium-enhanced CPC 
To prepare calcium phosphate cement powder in this research, 
one gram of tetracalcium phosphate (Ca4P2O9, TTCP) with a controlled 
mean particle size of 10 μm was synthesized following the method 
from the reaction of dicalcium phosphate dihydrate (CaHPO4·2H2O, 
DCPD; Merck Co. Kenilworth, New Jersey, United States) and calcium 
carbonate (CaCO3). Afterwards, disodium hydrogen phosphate 
(Na2HPO4; Merck) was added to the mixture; three different amounts 
of Na2HPO4 were added, in order to create 3 different powder-to-liquid 
ratios 1.205 ml (P/L = 0.83), 0.8 ml (P/L = 1.25), and 0.645 ml 
(P/L = 1.55). Finally, 3 wt% of synthesized nanostrontium-substituted 
hydroxyapatite (Sr-HA) (10% of calcium in hydroxyapatite was 
replaced with strontium) was added to the prepared cement. The 
calcium phosphate cement powder was mechanically ground to the 
mean particle size distribution of 3 mm; then it was vacuum-packed 
and g-ray-sterilized (20 kGy). The size of nanoparticles is evident in 
Fig. 1. 
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Fig. 1. Transmission electron micrograph of the synthetized nanostrontium 
hydroxyapatite. 
2.3. Characterization of nanostrontium-enhanced CPC 
2.3.1. X-ray diffraction analysis 
XRD patterns of the prepared calcium phosphate cements 
(CPCs) were obtained at room temperature using a very high-
resolution Cu-Kα radiation diffraction system (Equinox3000, INEL, 
Artenay, France) operating at a voltage of 40 kV and a current of 
30 mA. CPCs were analyzed in the 2θ angle range of 0–80°, and their 
patterns were studied to determine the crystal phases present in the 
samples. 
2.3.2. Fourier transform infrared spectroscopy (FTIR) analysis 
Infrared spectroscopy was carried out to determine the chemical 
composition of the prepared microspheres using FTIR (Nicolet, USA) 
operating in the wavenumber range of 400–4000 cm− 1 at the 
absorption mode. 
2.3.3. Simultaneous thermal analysis 
Simultaneous thermal analysis (STA) generally refers to the 
simultaneous application of thermogravimetry (TGA) and differential 
scanning calorimetry (DSC) to one and the same sample in a single 
instrument. A thermoanalyzer (STA; Polymer Laboratories PL-STA 
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1640) that was heated from room temperature up to ~ 1000 °C with 
the warming rate of 10 °C/min was used to record the conventional 
thermoanalytical curves. 
2.3.4. Scanning electron microscopy (SEM) 
The prepared microspheres were coated with a thin layer of gold 
by sputtering (Emitech K450X, England). The microstructure of the 
cement samples was observed using a scanning electron microscope 
(AIS-2100 780, Seron, South Korea) that operated at an acceleration 
voltage of 20 kV. 
2.3.5. Setting time measurement 
The powders of TTCP/DCPD were mixed with ratios of 1:1; and 
then were mixed with liquid phase for a minute at room temperature. 
Cement mixture was poured in a plastic mold to set. Setting time of 
the prepared cement was measured using Vicat test according to the 
ASTM-C-18798 standard. 
2.3.6. Mechanical properties 
In accordance with the ISO 14544, the modulus of the cements 
was measured using a mechanical testing machine (SMT-20, Santam). 
Cylindrical samples with length-to-diameter ratio of 2:1 (10 mm in 
length and 5 mm in diameter) were prepared. The load was applied at 
the cross-head speed of 1 mm/min until the specimen was compressed 
to approximately 30% of its original length. The elastic modulus was 
determined as the slope of the initial linear portion of the stress–strain 
curve. 
2.3.7. Inductively coupled plasma (ICP) analysis 
The interactions between the cements and a biological medium 
were carried out at 37 °C for 10, 20, and 110 days by immersing 
about 10 mg of cement in a simulated body fluid, the composition of 
which is almost identical to that of human plasma. These in vitro 
assays were conducted under static conditions: biological fluids were 
not renewed and therefore contained only limited amounts of P and 
Ca. Inductively coupled plasma atomic emission spectroscopy (ICP-
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AES; Agilent, USA) was used to analyze the biological fluid before and 
after cement interactions. 
2.3.8. Biological evaluation 
2.3.8.1. In vitro study 
2.3.8.1.1. MTT assay 
For measuring the cell viability of the prepared samples MTT (3-
(4, 5dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay 
was used. At first, under standard culturing conditions SAOS-2 cells 
were seeded on 96 well plates at a density of 1 × 104 cells per well. 
The cells were incubated on the samples for 3 and 7 days. After the 
incubation, the medium was removed and a medium containing 10% 
of MTT solution was added. Then, the plates were incubated at 37 °C 
for 4 h. The medium was then removed and 100 μl of solubilization 
buffer (Triton-X 100, 0.1 N HCl and isopropanol) were added to each 
well to dissolve the formazan crystals, which have been produced due 
to the activity of living cells in MTT solution. The absorbance of the 
lysate was measured in a microplate reader at a wavelength of 
570 nm. 
2.3.8.1.2. Alkaline phosphatase activity 
Alkaline phosphatase (ALP) is an enzyme whose production 
signifies proliferation and differentiation of osteoblasts. An ALP assay 
kit was used to measure ALP activity according to the manufacturer's 
protocol (Biocat, Heidelberg, Germany). Briefly, human osteosarcoma 
cell lines (SAOS-2) were seeded in 24-well cell culture plates at a 
density of 1 × 104 cells/cm2. The glass samples (n = 5) were placed in 
the wells. Three wells in the absence of glass samples were used as 
negative controls. The plates were incubated for 3 and 7 days at 37 °C 
in humidified air with 5% CO2 with half media. Then, the supernatant 
of each well was removed and the cell layer was rinsed twice with PBS, 
homogenized with 1 ml Tris buffer, and sonicated for 4 min on ice. 
Aliquots of 20 ml were incubated with 1 ml of a p-nitrophenyl 
phosphate solution at 30 °C for up to 5 min. Cellular alkaline 
phosphatase activity was determined by the conversion of p-
nitrophenyl phosphate to p-nitrophenol. It was monitored by following 
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the absorption at 405 nm. It was converted to enzyme activity using 
the p-nitrophenol standard absorption curve. 
2.3.8.2. In vivo study 
From the above in vitro experiments, the optimum powder-to-
liquid ratio for 3 wt% nanostrontium-enhanced CPC was determined as 
0.83 which could provide the best setting time, and hence proper for 
surgical procedures. This ratio was used for all the in vivo experiments 
mentioned below, as well as for producing the composite of 
nanostrontium-enhanced CPC with simvastatin-loaded poly(lactic-co-
glycolic acid) microspheres. 
2.3.8.2.1. Animals, surgical procedures, and experimental grouping 
The goal of this part was to comparatively evaluate the efficacy 
of the produced material in bone morphogenesis. Ten 10-week-old 
male Sprague–Dawley rats with an initial weight of 250–290 g were 
purchased from the Pasteur Institute for the in vivo study. Animals 
were anesthetized by means of intramuscular injection using ketamine 
(80 mg/kg) and xylazine (10 mg/kg). A full-thickness incision was 
made in the anterior region of the calvarium and a 5-mm diameter 
full-thickness bone defect was prepared using a trephine drill under 
continuous sterile saline irrigation. For the in vivo study, the prepared 
calcium phosphate cement was implanted within the calvarium defect. 
The defects were divided into control versus experimental groups: the 
control group was CPC implanted in the defect on the left parietal 
bone. The experimental defect was filled with nanostrontium-enhanced 
CPC. Also, defects without implanted cements were made in the frontal 
bone as negative controls. Soft tissues were sutured to achieve 
primary closure. Four weeks after implantation, the animals were 
sacrificed. The area of the original surgical defect and the surrounding 
tissues were removed en bloc and fixed in 10% neutral buffered 
formalin solution and then decalcified in 10% (v/v) nitric acid. Tissues 
were embedded in a paraffin block and then serial sectioned using a 
microtome to slides of approximately 4–6 μm thickness. 
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2.3.8.2.2. Histological analysis and histomorphometry 
Slides with tissue sections were de-paraffinized and hydrated 
through series of xylene and alcohol. The tissue slides were stained 
with hematoxylin & eosin (H&E) and observed under an optical 
microscope for the histological observation (E400, Nikon, Tokyo, 
Japan). 
2.3.8.2.3. Radiographic examination 
Radiographs were taken using an X-ray machine (Intra 
Planmeca-Helsinki, Finland), after sacrificing. The percentage of bone 
formation within the defects was evaluated blindly and independently 
by two observers. 
2.4. Preparation of the composite of simvastatin-loaded 
poly(lactic-co-glycolic acid) (SIM-loaded PLGA) 
microspheres plus nanostrontium-CPC 
In order to create nanostrontium-CPC-incorporated simvastatin-
loaded poly(lactic-co-glycolic acid) (SIM-loaded PLGA), first, SIM-
loaded PLGA microspheres were produced. The production and 
evaluation of SIM-loaded PLGA microspheres [without CPC 
composition] including their simvastatin release kinetics are reported 
in another article.34 Briefly put, they were prepared by oil-in-water 
(O/W) emulsion/solvent evaporation method under magnetic stirrer, 
and later by centrifuging, and 24 h of freeze drying.34 Then 3 wt% 
nanostrontium-CPC was produced as explained above (0.5 g of TTCP 
with a controlled mean particle size of 10 μm was synthesized and 
blended with 0.5 g of DCPD, and 3 wt% of synthesized nanostrontium-
substituted hydroxyapatite). Afterwards, 0.1 g of SIM-loaded PLGA 
microspheres was added to the powder cement. Subsequently, for 
setting of the cement, 1.205 ml (Powder/Liquid = 0.83) of disodium 
hydrogen phosphate (Na2HPO4; Merck) was added to the mixture. The 
‘SIM-loaded PLGA microspheres + nanostrontium-CPC’ composite was 
vacuum-packed and g-ray-sterilized (20 kGy). 
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2.5. Characterization of the composite of SIM-loaded 
PLGA microspheres and nanostrontium-CPC 
2.5.1. SEM 
The composite was scanned as described above. 
2.5.2. In vivo evaluations 
The efficacy of the produced composite in osteogenesis 
induction was compared with other biomaterials (3 wt% 
nanostrontium-enhanced CPC, and 3 wt% nanostrontium-enhanced 
CPC plus simvastatin) and control groups. 
2.5.2.1. Animals, surgical procedures, and experimental groups 
Ten mature, male New Zealand white rabbits, with an average 
weight of 3.5 kg, were purchased from the Pasteur Institute. Each 
rabbit was housed in an individual cage, in Iranian Tissue Bank and 
Research, Tehran, Iran. Food and water were available ad libitum. 
Prophylactic antibiotic (gentamicin 6 mg/kg) was administered 3 h 
before surgery. The animals were anesthetized with injection of 
ketamine at a dosage of 40 mg/kg IM (ketamine hydrochloride, 
Trittau, Germany, Rotexmedica) and Xylazine at a dosage of 5 mg/kg 
IM (Xylazine 2%, Alfasan-woerden-Holland). During the surgery, 
lidocaine hydrochloride was locally administered. After shaving and 
disinfecting the surgical site with 10% pivodine iodine, skin incision 
was made in dorsal part of the cranium. Then, periosteum was flapped 
carefully and parietal bone was exposed. Full thickness bone defects, 
8 mm in diameter, were parallel trephined in the parietal bone without 
damaging the dura (trephine height was about the width of the bone). 
An 8-mm Trephine bur (rotary motor, W&H, Austria) was used to 
create the defects, under constant irrigation with sterile normal saline 
to prevent overheating of the bone margins. 
In each animal, 5 sites were prepared: a negative control, which 
was a defect left empty after trephining the bone. A positive control, 
which was an experimentally made defect, filled with the bone 
trephined from the site of the negative control. A third defect filled 
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with “SIM-loaded PLGA + nanostrontium-enhanced CPC” composite. A 
fourth defect filled with 3 wt% nanostrontium-enhanced CPC. And a 
fifth defect filled with a combination of 3 wt% nanostrontium-
enhanced CPC plus simvastatin. The coordinates of defect areas were 
scaled and noted down. 
Afterwards, the periosteum and muscles were carefully 
repositioned on the outer surface of the implants and sutured in place 
using catgut 3-0. Afterwards, the skin was sutured with silk 2-0. After 
the surgery, the rabbits were housed with free access to water and 
food. Injection with Enrofloxacin 5 mg/kg (Enro-10%, Maghull, 
Liverpool, UK) was given every 12 h, for 48 h, post-operation. All the 
experiments and protocols described in the present study were 
performed in accordance with the guidelines for the care and use of 
laboratory animals. 
2.5.2.2. Histological study and histomorphometry 
Animals were euthanized 8 weeks after surgery by vital 
perfusion, with the intravenous injection of pentobarbital. Defect areas 
were separated and fixed in 10% formalin for 48 h. Samples were 
decalcified by 10% formic acid for 30 days, dehydrated in ethanol, and 
then embedded in 10 × 10-mm paraffin blocks. Samples were then cut 
into serial 4 μm sections. Three sections from the central area of each 
defect were selected, stained with H&E, and subjected to 
histomorphometric analysis. Bone formation was observed under a 
Nikon light microscope (E400, Tokyo, Japan) at magnification × 400, 
and analyzed using computerized image processing software. 
2.6. Statistical analysis 
Data values obtained in the experiments were statistically 
analyzed by one-way analysis of variance (ANOVA) and Tukey post hoc 
test. The level of significance was set at 0.05. 
3. Results and discussion 
Bone defect caused by tumor, trauma and other diseases can 
often be repaired by bone graft. However, its clinical application is 
limited due to a second surgical site for access to retrieved graft and 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Materials Science and Engineering: C, Vol 69 (December 1, 2016): pg. 780-788. DOI. This article is © Elsevier and 
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
15 
 
other complications for autogenous bone graft as well as the limited 
availability, rejection and the spread of disease for allograft. With the 
development of material and biological science, bone tissue 
engineering provides a new method to restore the tissue loss or 
failure, which aims to develop biological substitutes to repair and 
improve the function of the organization. The basic requirements for 
an ideal scaffold for bone tissue engineering include several factors as 
follows.35,36,37,38 Good biocompatibility: In addition to meet the non-
toxic, non-teratogenic and other general requirements, it should be 
also conducive to the cell adhesion and proliferation, and its 
degradation products should have no adverse effects on the cell 
adhesion, growth and differentiation. Good biodegradability: Scaffold 
material should be degraded after completion of its supporting role, 
and the degradation should be adapted to the formation of bone 
tissue, thus contributing to the reconstruction of bone. A 3D porous 
structure: This structure not only provides a large surface area and 
space, which is conducive to the growth of cell adhesion, extracellular 
matrix deposition, nutrients infiltration and metabolite discharge, but 
also promotes the ingrowth of blood vessels and nerves. Moldability 
and relatively high mechanical strength: Scaffold material should be 
formed into a certain shape with a certain mechanical strength, which 
provides mechanical support for the new tissue and allows for weight 
bearing. Good osteoconductivity and osteoinductivity: Scaffolds should 
have surface chemical properties and microstructure to support the 
bone cell growth and migration.35,36,37,38 
3.1. Results and discussions pertaining to the 
nanostrontium-enhanced CPC 
3.1.1. XRD analysis 
According to diffraction patterns of the prepared samples, TTCP 
and HA peaks were observed between 0° ≤ 2θ ≤ 80° with no 
additional phases such as CaO, perhaps because TTCP was obtained by 
means of quenching method at 1500 °C after 12 h instead of furnace-
cooled method (which might result in production of TTCP, HA and free 
CaO from decomposition of TTCP).39 As a result, the optimum process 
to obtain the high contents of TTCP and remove CaO phase is a 
quenching after holding 12 h. In additional, it can be concluded that all 
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the DCPD has transformed into HA in the synthesized cement (Fig. 2). 
The proportion of powder to liquid is a significant feature of cements 
as it can affect both bioresorbability and rheological properties.40 
According to the Fig. 2, it seems that by increasing the ratio of 
Powder/Liquid, crystallinity of the prepared cement might also 
increase. This might imply an increase in crystallinity of HA in 
comparison with apatite cements formed in an aqueous environment, 
which have poorer crystalline HA as the end product.40 The substitution 
of calcium with strontium can alter the crystal structure; this is visible 
in Fig. 2 as well-defined and sharp peaks in association with 
incorporation of Sr ions. This is in agreement with a high degree of 
crystallinity of cement reported earlier.41,42 On the other hand, the 
broadening is more obvious for the samples with smaller amounts of 
strontium because there exists a greater difficulty for HA to host the 
larger Sr ion than for HA-containing Sr to host the smaller calcium ion 
with respect to their ionic radii (Ca2 + ionic radius = 0.100 nm; Sr2 + 
ionic radius = 0.118 nm).41 Additionally, a shift of diffraction peaks to 
lower 2θ values with Sr addition was observed; which this might 
indicate a gradual increase in d-spacing.42 Meanwhile, in the samples 
with no strontium hydroxyapatite (Sr-HA), no significant increase in 
crystallinity was observed. 
 
Fig. 2. XRD pattern of CPC and Sr-HA-CPC with different P/L ratios. At 2θ = 0, all the 
six lines start at zero on the vertical axis. Three P/L ratios have been artificially 
separated by adding 200 and 400 units to the ratios 1.25 and 1.55, respectively. For 
each P/L ratio, the results pertaining to CPC and Sr-HA-CPC are overlapped 
intentionally. Violet circles mark hydroxyapatite. Red circles indicate both 
hydroxyapatite and tetracalcium phosphate. 
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3.1.2. FTIR analysis 
In Fig. 3, FTIR spectra of the CPC (prepared with and without 
3 wt% Sr-HA of different P/L ratios (0.83, 1.25, and 1.55)) are 
exhibited. There was no considerable difference between CPC with and 
without strontium. Analyses of the spectra are as follows: FTIR spectra 
of the three samples follow a single model. The FTIR analysis 
determines the functional groups of the samples; since the functional 
groups are similar in all three prepared cements, FTIR similarity is 
expected. The bands in the range of 3488 to 3497 cm− 1 spectral of the 
three types of cements are related to vibration of adsorbed water and 
presence of hydroxyl groups. Incorporation of Sr ion instead of Ca 
decreases the relative intensity of the bands of OH– stretching. In this 
case vibration modes as well as OH– stretching mode shift to high 
wave numbers, while OH– liberation band shifts to lower wave 
numbers, in agreement with results reported for Ca-HA and Sr-HA.43 
The bands 1640 to 1643 cm− 1 are related to absorption of H2O. The 
bands at 512–517 cm− 1, 520–530 cm− 1 and 1010–1034 cm− 1 are 
related to V2PO4− 3, V3PO4− 3, and V1PO4− 3 respectively that could be 
due to presence of calcium phosphate compounds (TTCP, DCPD and 
HA) in the samples. FTIR results of Bigi et al.41 pertaining to pure Ca-
HA showed that phosphate groups shift to lower wave numbers with 
incorporation of Sr ions and formation Sr-HA. The predominant factor 
causing the shift in the internal PO4 frequencies to lower energies is 
the reduced anion-anion repulsion concomitant with an increased 
anion-anion separation on increasing cation radius. The influence of Sr 
in shifting phosphate group is attributed to the increasing average 
dimensions of the cation,41 and indicates an increase of irregularity in 
the HA structure around phosphate sites through the incorporation of 
Sr. These bands can also be related to formation of hydroxyapatite by 
the reaction happening between the liquid and powder phases of the 
cement. The observed bands at 883–881 cm− 1 are related to 
carbonate groups; this might imply the absorption of carbonate from 
the environment. 
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Fig. 3. FTIR spectra of prepared CPC (A) and Sr-HA-CPC (B) with different P/L ratios. 
1: V2PO4− 3, 2: carbonate; 3: V1PO4− 3, 4: water; 5: OH. 
3.1.3. Thermal analysis 
Four phases were observed in thermal analysis. In the first 
phase (up to 280 °C), the surface humidity is absorbed. The weight 
reduction of the samples begins at 25 to 280 °C during which about 
1 mg of weight is lost, probably as a result of water evaporation. In 
the second phase, the sample experienced a slight weight loss (about 
0.1 mg) in the temperature range of about 280 to 375 °C which can be 
related to the crystallization of the powders from the amorphous.44 The 
third stage (375 to 550 °C) showed about 0.5 mg weight loss, and 
might be related to reduction of hydroxyl groups with decomposition of 
HPO4− 2 anions to pyrophosphate anions P2O7− 4. The fourth stage 
(about 2.3 mg weight loss at 550 to 880 °C temperatures) might be 
attributed to the release of CO2 gas during endothermic decomposition 
of CO3− 2 and/or decomposition of pyrophosphates to biphasic mixtures 
[as in P2O74− → 2PO43− + H2O].45 
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3.1.4. SEM observations 
The SEM micrographs of CPC and Sr-HA-CPC (Fig. 4) indicate 
that with increasing the P/L ratio, the formation of hydroxyapatite 
crystals (arising from the interaction of solid and liquid phases) might 
decrease. The incorporation of Sr within Ca site causes a dramatic 
increase in crystallinity of hydroxyapatite. Strontium atoms can occupy 
both M(1) and M(2) sites of the apatite structure, depending on the 
amount of strontium. At very low Sr contents, the occupancy of M(1) 
is more probable, while samples containing > 10 atom% Sr 
demonstrated a preferential Sr occupancy at M(2) sites.41 The M(2) 
sites allow a better accommodation of the bigger Sr atoms; whereas in 
the M(1) sites, metals are hardly aligned in columns parallel to the c-
axis. Perhaps, longer average M(1)-O distances might allow the 
accommodation of a larger cation. With increase of the number of 
bigger ions, the repulsion between atoms in the M(1) site might trigger 
an enlargement of the c-axis. Furthermore, the greater extent of Sr 
distribution might cause a significant discontinuity in the cell 
parameter variation.46 It was also reported that within each specific Sr 
occupancy, the relationship between the excess energies Ex of the solid 
solution Sr-HA-X structures and sites for substitution of Sr is Ex site 
(1) < Ex mixed sites < Ex site (2). Hence, Sr incorporation at site 1 is 
more favorable than at mixed sites followed by site 2.47 
 
Fig. 4. SEM micrographs of prepared CPC without 3 wt% Sr-HA (A to C) and with 
3 wt% Sr-HA (D to F). The P/L ratios are 0.83, 1.25 and 1.55, from left to right (i.e., 
from A to C, and from D to F). 
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3.1.5. Setting time 
With an increase in the powder-to-liquid ratio of 3 wt% Sr-HA-
CPC, the setting time might reduce (Table 1). The relative solubility of 
phases of TTCP and DCPD is regarded as a major factor affecting the 
setting time of calcium phosphate. HA was precipitated according to 
the following equation: 2Ca4(PO)2O + 2CaHPO4 → Ca10(PO4)6 (OH)2. 
Table 1. Setting time of the prepared CPC with 3 wt% Sr-HA with different 
P/L ratio. 
P/L ratio Setting time (min) 
0.83 28.7±0.4 
1.25 9.3±0.1 
1.55 2.2±0.2 
Applying Na2HPO4 (as a liquid phase) to prepare the cement 
increases the rate of hydroxyapatite formation and decreases the 
setting time. In other words, lower powder-to-liquid ratios might 
elongate the working and setting time of the mass, delaying the 
supersaturation of hydrate phases (i.e., hydroxyapatite In apatite 
cements).48 
3.1.6. ICP analysis 
The release of strontium after interaction in the Sr-free medium 
is presented for cement samples in Table 2. This might be useful for 
osteoporosis therapy.49,50 The smooth delivery of Sr2 + ions in biological 
conditions might be attributed to the substitution of Ca for Sr in the 
Sr-enhanced cements.49,51 After this interaction, some strontium 
remains in the hydroxyapatite and might serve as a reservoir for 
future osseointegration of implants upon bone re-modeling.49,51 
Table 2. Release of Sr, Ca and P ions as a function of interaction time for 
cement samples (P value < 0.01). 
Days Ca (ppm) P (ppm) Sr (ppm) 
10 39.6±4.7 60.9±3.6 0.1 
20 62.8±8.9 70.2±7.7 0.3±0.1 
110 138.6±13.4 121.8±15.8 0.8±0.1 
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3.1.7. Mechanical properties 
Mechanical properties of the cement are given in Fig. 5. 
Although the ceramic samples behaved similar to other ceramic bone 
cements but their mechanical properties were smaller compared to 
their corresponding values in spongy and compact bone. 
 
Fig. 5. Mechanical properties of the prepared cement. The final amounts of the 
Young's modulus and ultimate strength are 33.06 ± 2.06 and 2.24 ± 0.12 MPa, 
respectively. 
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3.1.8. Biological evaluations 
3.1.8.1. In vitro study 
3.1.8.1.1. MTT assay 
Cytocompatibility of the prepared cements was assessed using 
MTT assay (Fig. 6). After 14 days of incubation, the cell viability 
decreased for all samples, whereas, the reduction was insignificant for 
all of them. Addition of 3 wt% of nanostrontium hydroxyapatite (Sr-
HA) increased the biocompatibility of the prepared cements 
(P < 0.05). The prepared cements have proper biocompatibility and 
are suitable for use as bone cement. It has been proved that Sr ions 
can stimulate cellular responses. The influence of strontium ions on 
viability of osteoblastic cells might be dose-dependent, owing to the 
lower viability rate of the osteoblasts on calcium phosphate cements 
compared with their viability on other Sr-hydroxyapatite cements. In 
agreement with other studies, our findings as well indicated that the 
incorporation of Sr in hydroxyapatite cement might encourage new 
bone formation.42,52 Although, it is known that Sr incorporation 
enhances cell proliferation, its optimum concentration is still 
controversial. Park et al.53 found that Sr ions release at 103–135 ppb 
increased the differentiation of osteoblast. Also, other results suggest 
that Sr alone at concentrations between 1.21 and 3.24 does not 
impact the proliferation of osteoblast cells.42 
 
Fig. 6. Cell proliferation of SAOS-2 cells proliferated on the CPC with and without 
3 wt% Sr-HA with different P/L ratios along with negative control after incubation for 
7, and 14 days. 
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3.1.8.1.2. Alkaline phosphatase 
Measurement of ALP activity is considered one of the criteria 
necessary for osteoblast activity. Fig. 7 shows the results of the ALP 
activity of different prepared cements after 3 and 7 days of incubation, 
indicating a significant increase in ALP activity by adding Sr-HA 
(P < 0.05). This might be attributed to the presence of strontium ions 
which might increase the activity of bone cells. The cements with P/L 
ratio of 1.25 had the highest level of alkaline phosphatase activity 
compared to P/L ratios of 1.55 and 0.83. Therefore, the P/L ratio of 
1.25 was selected as the optimum ratio in CPC. It is noteworthy that 
the biology activity of Sr-containing cement is also attributed to the 
influences on crystallinity and expansion of its crystal lattice due to the 
larger size of Sr compared to Ca. In addition, according to the SEM 
analysis (Fig. 4), the samples containing Sr consisted of larger, 
needle-like crystals. As a result, the small tightly entangled crystal can 
provide more nucleation sites for the formation of apatite crystals.54,55 
 
Fig. 7. ALP activity test for SAOS-2 cells proliferated on the CPC with and without 
3 wt% Sr-HA with different P/L ratio along with negative control after incubation for 7 
and 14 days (P > 0.05). 
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3.1.8.2. In vivo study 
3.1.8.2.1. Histological analysis and histomorphometry 
The in vivo bone tissue response towards three samples was 
evaluated by means of histological examination, after surgical 
placement of the materials “3 wt% Sr-HA/CPC”, “CPC” and the control 
in rat for 4 weeks (Fig. 8). After 4 week post-implantation, no severe 
inflammation, tissue necrosis or tissue rejection was observed. 
Generally, fibrous connective tissue and blood vessels grow into the 
macropores, contributing to the early fixation of the samples. 
 
Fig. 8. Implantation steps in rat (the frontal socket is negative control). 
CPC gradually dissolves in the body and releases calcium and 
phosphate ions.56 The histomorphometric analysis in this study 
displayed an increase in the bone formation for the Sr-CPC (ANOVA's 
P < 0.05) in comparison with the defect areas filled with CPC without 
Sr and the negative control (empty defect). It should also be noted 
that the formation of bone at both the periphery and center of fracture 
defect area for all the samples were visible. This can be attributed to 
the local release of Sr from cement that might improve osteogenesis. 
Molecular-biological activities (enhanced expression of BMP2, 
osteocalcin and OPG) were observed in this study indicating an 
increased formation of new bone in Sr-containing cement in 
comparison with CPC and the negative control. Furthermore, it is 
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possible that strontium's osteogenic activity preserved within the 
cement.25,57 The uptake of strontium by the bone may increase the 
bone volume by increasing the sites of bone formation and decreasing 
bone resorption, without affecting the rate of osteogenesis and bone 
mineralization.54 
3.1.8.2.2. Radiographic analysis 
Strontium-containing cement is inherently radiopaque without a 
need to additional materials for radio-examination. No inflammatory 
response and no necrosis were found in the rats implanted with Sr-HA 
cement. The similarity of minerals in Sr-HA cement and bone promotes 
the fusion of the material to the bone during osteogenesis. As a 
consequence, Sr-HA bioactive cement might have the potential to be 
utilized to treat osteoporotic fractures.58 
3.2. Results and discussions pertaining to the 
composition of SIM-loaded PLGA 
microspheres + nanostrontium-enhanced CPC 
3.2.1. SEM observations 
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The SIM-PLGA + Sr-PC scaffold possessed suitable pore sizes 
and interconnected pores (Fig. 9).
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Fig. 9. SEM micrographs of cement containing SIM-loaded PLGA. 
3.2.2. In vivo evaluations 
The surgical steps for rabbit are presented in Fig. 10. After 
8 weeks of in vivo application, only a small amount of bone had been 
regenerated in the control group (Fig. 11). This newly formed bone 
was only localized at the boundary of the defect, and the defects were 
mostly filled with soft tissue. On the other hand, the other groups 
showed new bone formation within the bone cements filling the defect. 
The new bone area for the control group was significantly lower than 
the other groups (Tukey's P < 0.01). A significant difference was found 
in the osteogenesis induced by the groups sham (negative) control 
(16.96 ± 1.01), bone materials (positive control) (32.28 ± 4.03), 
nanostrontium-CPC (24.84 ± 2.6), nanostrontium-CPC-simvastatin 
(40.12 ± 3.29), and SIM-loaded PLGA + nanostrontium-CPC 
(44.8 ± 6.45) (ANOVA's P < 0.001). All the pairwise comparisons were 
significant (Tukey's P < 0.01), except that of nanostrontium-CPC-
simvastatin and SIM-loaded PLGA + nanostrontium-CPC. This 
confirmed the efficacy of the SIM-loaded PLGA + nanostrontium-CPC 
composite, and its superiority over all materials except SIM-containing 
nanostrontium-CPC (Table 3). SIM is widely used in clinical lipid-
lowering drugs, and its osteogenic potential for bone metabolism has 
become a hot research field in recent years.28,32,33 SIM plays a role in 
promoting new bone formation and regulation, which is related to 
BMP-2 and VEGF expression of osteoblasts.21,22 In our study, we found 
the scaffolds co-cultured with BMSCs in vitro improved the cell 
proliferation and significantly induced osteogenic differentiation, thus 
promoting the ALP activity and enhancing their osteogenic capability. 
Drug utilization rate of systemic administration is limited due to its 
potential systemic side effects. Topical administration makes a higher 
drug concentration at the bone defect site, leading to suppressed drug 
utilization rate.23 The results of the in vivo experiments showed that 
the pure CPC group had the least new bone formation area at 8 weeks 
after implantation. However, the new bone formation area of SIM-
loaded group was significantly higher than other groups, indicating 
that of topical administration in vivo and satisfactory osteogenic effect 
could be obtained through the application of SIM-PLGA + Sr-CPC 
scaffold. Pore size and porosity of the scaffold are important conditions 
for ingrowth of new bone tissue, and it is desirable to provide a 
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suitable pore space for the bone formation, vascular ingrowth and 
deposition of extracellular matrix. Osteoblast migration requires a 
minimum pore size of 100 μm, whereas a suitable fibroblast growing 
space is 180–300 μm.24,25 Therefore, in order to provide the most basic 
environment of osteoblast growth, the pore size of scaffolds should be 
around 200 μm. However, only a suitable pore size is not enough for 
porous scaffold material.26 It is difficult to cause the new bone to grow 
inside the scaffold if the connection between the porosity is not 
sufficient. The interconnected micropores on the pore walls of 
macropores are conducive to new blood vessels to grow deeper into 
the scaffold, to supply nutrients and discharge metabolites, which is 
beneficial to the new bone formation. In the present study, in vitro 
methods were adopted to test the response of BMSCs to the SIM-
PLGA + Sr-CPC scaffold. The results suggested that SIM-PLGA + Sr-
CPC scaffolds promoted a higher degree of osteogenic differentiation 
compared with pure scaffolds. It also indirectly indicated that SIM 
could play a role in promoting the osteogenic differentiation of BMSCs. 
During our investigation, all rabbits were under good health and did 
not show any surgery complications. At 8 weeks, the implanted SIM-
PLGA + Sr-CPC scaffolds and tissue cells exhibited good 
biocompatibility. Radiographic and histological investigations were 
performed to assess the process of bone tissue formation. 
 
Fig. 10. The surgical steps in rabbit (the first row), and the outcome (the second 
row). 
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Fig. 11. Histological images at 8 weeks, (a) no augmentation (control group; ctrl), (b) 
bone materials (BM), (c) Sr-CPC (C), and (d) Sr-CPC containing SIM (CS) and (e) Sr-
CPC containing SIM loaded PLGA microsphere (CPS). 
 
Table 3. New bone formation (%) in rabbit. 
Groups Mean SD 95% CI 
 
Negative control 16.96 1.01 16.33 17.59 
Bone materials 32.28 4.03 29.78 34.78 
Sr-CPC 24.84 2.60 23.23 26.45 
Sr-CPC+SIM 40.12 3.29 38.08 42.16 
Sr-CPC-SIM-PLGA 44.80 6.45 40.80 48.80 
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This study also had limitations. Young animals have better 
physical condition as well as more resistance to operation compared to 
old ones. Therefore, only young animals were included. This may limit 
the clinical relevance of the results. Moreover, it was better to test a 
broader range of powder-to-liquid ratios, in order to identify the 
optimized ratio with a greater confidence. In addition, SEM 
interpretation is subjective and prone to bias. 
4. Conclusions 
4.1. Nanostrontium-enhanced CPC 
In conclusion, XRD analysis demonstrated that by increasing the 
ratio of powder-to-liquid, crystallinity of the prepared cement 
increases. The substitution of calcium by strontium in CPC can alters 
the crystal structure. According to the SEM observations, by increasing 
the P/L ratio of CPC, the formation of hydroxyapatite crystals arising 
from the interaction of solid and liquid phase of cement will be 
reduced. Sr-CPC has better ALP activity and biocompatibility (indicated 
by MTT assay) and induced higher bone regeneration. 
4.2. SIM-loaded PLGA microspheres + nanostrontium-
enhanced CPC 
The prepared composite exhibited a good interconnective pore 
structure for cell seeding and transplantation. Sr-CPC containing 
simvastatin-loaded PLGA microsphere demonstrated a higher level of 
osteogenic differentiation. 
The key findings of this study can be summarized as follows. 
The addition of nanostrontium can enhance the chemophysical 
properties of CPC and increase the crystallinity of hydroxyapatite while 
being cytocompatible and encouraging osteogenesis without inducing 
inflammatory responses or other disturbances for the tissue. Higher 
P/L ratios of nano-Sr-CPC might improve the chemomechanical 
properties and reduce the setting time. The composition of nano-Sr-
CPC with PLGA microsphere loaded with simvastatin creates a porous 
material that can boost the osteogenesis about twice compared to the 
osteogenesis induced by nano-Sr-CPC. 
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